Home » Topics » Regulatory » Health Canada

Health Canada
RSS

ViaCyte cleared to begin trial of PEC-Direct in U.S. and Canada

May 23, 2017

Health Canada approves Roche's cobas EGFR Mutation Test v2

March 16, 2017

Canada first to approve Kevzara

Feb. 1, 2017

VBI Vaccines cleared to begin phase I study of CMV vaccine candidate in Canada

June 27, 2016

Antibe Therapeutics cleared to begin phase II study of ATB-346

March 7, 2016

Takeda's NDS for ixazomib accepted for priority review in Canada

Feb. 18, 2016

Tobira Therapeutics initiates a program to evaluate cenicriviroc for the treatment of PSC

Jan. 12, 2016

ExCellThera cleared to begin phase I/II trial of ECT-100 for expansion of hematopoietic stem cells

Dec. 23, 2015

Health Canada approves Cingal for osteoarthritis knee pain

Nov. 5, 2015

Xenon initiates phase I trial of XEN-801 for acne

Sep. 29, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...